ROSSARI₹414.70-2.95%
60/100
0100 · strongest
good
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %ROSSARI financial summary
For Mar 2026, Rossari Biotech Ltd reported revenue of ₹1,752 crore, which grew 22.3% from the previous year. Net profit was ₹143 crore, which grew 24.3% year on year, on an operating margin of 12%. Earnings per share came in at ₹25.79. Annual results are available for 12 financial years, from Mar 2011 to Mar 2026.
| Revenue | ₹1,752 crore |
|---|---|
| Net profit | ₹143 crore |
| Operating margin | 12% |
| EPS | ₹25.79 |